Bypassing tumor-specific and bispecific antibodies: triggering of antitumor immunity by expression of anti-FcgammaR scFv on cancer cell surface.

about

The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity.

P2860

Q26851545-9E898715-AA2F-4551-94C7-7A7780B21F44 Q40632755-23A1623E-FE4A-4CA3-A58D-C4A7F67CF0D2

P2860

Bypassing tumor-specific and bispecific antibodies: triggering of antitumor immunity by expression of anti-FcgammaR scFv on cancer cell surface.

Item

http://www.wikidata.org/entity/Q45884227

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh

2001年學術文章

@zh-hant

name

Bypassing tumor-specific and b ...... R scFv on cancer cell surface.

@en

Bypassing tumor-specific and b ...... R scFv on cancer cell surface.

@nl

type

Item

label

Bypassing tumor-specific and b ...... R scFv on cancer cell surface.

@en

Bypassing tumor-specific and b ...... R scFv on cancer cell surface.

@nl

prefLabel

Bypassing tumor-specific and b ...... R scFv on cancer cell surface.

@en

Bypassing tumor-specific and b ...... R scFv on cancer cell surface.

@nl

P1476

Bypassing tumor-specific and b ...... R scFv on cancer cell surface.

@en

P2093

Gruel N

http://www.w3.org/2001/XMLSchema#string

Teillaud JL

http://www.w3.org/2001/XMLSchema#string

P2860

Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses.

Bispecific antibodies in cancer therapy.

Signaling pathways engaged by NK cell receptors: double concerto for activating receptors, inhibitory receptors and NK cells.

Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity.

Human neutrophil Fc gamma receptor distribution and structure

Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor.

Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells.

Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization.

Software for the quantitative evaluation of in vitro monoclonal antibody production from ELISA data.

Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.

P2888

sj.gt.3301575

P304

1721-1728

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3301575

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wolf Hervé Fridman

P577

2001-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11470253

http://www.w3.org/2001/XMLSchema#string

P6179

1041787729

http://www.w3.org/2001/XMLSchema#string

P698

11892840

http://www.w3.org/2001/XMLSchema#string

Bypassing tumor-specific and bispecific antibodies: triggering of antitumor immunity by expression of anti-FcgammaR scFv on cancer cell surface.

about

P2860

P2860

Bypassing tumor-specific and bispecific antibodies: triggering of antitumor immunity by expression of anti-FcgammaR scFv on cancer cell surface.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698